Simulation

DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD

Retrieved on: 
Tuesday, January 30, 2024

The nomination of novel Kv1.3 inhibitor DPT0218 for the treatment of various immunological diseases including IBD and AD.

Key Points: 
  • The nomination of novel Kv1.3 inhibitor DPT0218 for the treatment of various immunological diseases including IBD and AD.
  • Inhibition of Kv1.3 therefore offers a potential opportunity to specifically impair inflammatory immune cell activity and proliferation, including in antigen-activated T cells.
  • Long-lived memory T-cell populations, particularly tissue resident subsets, may contribute to the chronicity of IBD and represent a potential target for therapy[4].
  • It has shown positive results in preclinical animal models of various autoimmune diseases such as IBD and AD.

Simulators Market worth $26.1 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, January 23, 2024

The demand for customized and hands-on training experiences, coupled with evolving regulatory standards, further fuels the growth of training services.

Key Points: 
  • The demand for customized and hands-on training experiences, coupled with evolving regulatory standards, further fuels the growth of training services.
  • As industries prioritize continuous skill development, the training services segment is poised for substantial expansion, presenting lucrative opportunities in the dynamic simulator market.
  • By platform, the Simulator market for the maritime segment is projected to grow at the highest CAGR during the forecast period.
  • Simulators catering to passenger ship scenarios offer comprehensive training for navigation, crisis management, and evacuation procedures, addressing the industry's evolving needs.

Simulators Market worth $26.1 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, January 23, 2024

The demand for customized and hands-on training experiences, coupled with evolving regulatory standards, further fuels the growth of training services.

Key Points: 
  • The demand for customized and hands-on training experiences, coupled with evolving regulatory standards, further fuels the growth of training services.
  • As industries prioritize continuous skill development, the training services segment is poised for substantial expansion, presenting lucrative opportunities in the dynamic simulator market.
  • By platform, the Simulator market for the maritime segment is projected to grow at the highest CAGR during the forecast period.
  • Simulators catering to passenger ship scenarios offer comprehensive training for navigation, crisis management, and evacuation procedures, addressing the industry's evolving needs.

Scientific Systems Conducts Live Fully Autonomous Multi-Vehicle Defensive Counter Air Missions

Retrieved on: 
Tuesday, January 16, 2024

WOBURN, Mass., Jan. 16, 2024 /PRNewswire/ -- Scientific Systems Company, Inc. (SSCI) successfully flew multiple flight tests of its Collaborative Mission Autonomy (CMA) software running on a live General Atomics Aeronautical Systems, Inc. (GA-ASI) MQ-20 Avenger® Unmanned Combat Air Vehicle. In these November 2023 flight tests, CMA software commanded a mixed team of Live, Virtual, and Constructive (LVC) MQ-20 platforms to execute a fully autonomous multi-vehicle Defensive Counter Air mission.

Key Points: 
  • In these November 2023 flight tests, CMA software commanded a mixed team of Live, Virtual, and Constructive (LVC) MQ-20 platforms to execute a fully autonomous multi-vehicle Defensive Counter Air mission.
  • Scientific Systems' software was embedded onboard all the live, virtual, and constructive MQ-20 platforms, successfully managing the autonomous mission at the edge to compensate for communication and coordination challenges.
  • Scientific Systems' algorithms use operator pre-mission inputs to generate tailored, coordinated flight behaviors that address mission objectives by optimizing aircraft positioning, engagement parameters, and defensive maneuvers.
  • Earlier Scientific Systems test flight programs have successfully demonstrated a variety of air-to-ground, and ground support missions.

Synopsys to Acquire Ansys, Creating a Leader in Silicon to Systems Design Solutions

Retrieved on: 
Tuesday, January 16, 2024

SUNNYVALE, Calif. and PITTSBURGH, Jan. 16, 2024 /PRNewswire/ -- Synopsys (NASDAQ: SNPS) and Ansys (NASDAQ: ANSS) today announced that they have entered into a definitive agreement under which Synopsys will acquire Ansys. Under the terms of the agreement, Ansys shareholders will receive $197.00 in cash and 0.3450 shares of Synopsys common stock for each Ansys share, representing an enterprise value of approximately $35 billion based on the closing price of Synopsys common stock on December 21, 20233. Bringing together Synopsys' pioneering semiconductor electronic design automation (EDA) with Ansys' broad simulation and analysis portfolio will create a leader in silicon to systems design solutions.

Key Points: 
  • Bringing together Synopsys' pioneering semiconductor electronic design automation (EDA) with Ansys' broad simulation and analysis portfolio will create a leader in silicon to systems design solutions.
  • "The megatrends of AI, silicon proliferation and software-defined systems are requiring more compute performance and efficiency in the face of growing, systemic complexity.
  • "Joining forces with Ansys, a company we know well from our long-standing partnership, is the latest example of how Synopsys remains at the forefront.
  • The conference call can be accessed by dialing 800-245-3047 (domestic) or 203-518-9765 (international) and entering SYNOPSYS as the conference ID.

Valiant Awarded $118.5M Contract to Provide Simulator and Academic Instructor Pilots to Pacific Air Forces

Retrieved on: 
Thursday, January 11, 2024

HERNDON, Va., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Valiant announced today that it has been awarded a $118.5M contract by the U.S. Air Force (USAF) to provide Simulator and Academic Instructor Pilots (SIM-IPs) to the Pacific Air Forces (PACAF), reaffirming Valiant’s commitment to enhancing USAF mission-readiness.

Key Points: 
  • HERNDON, Va., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Valiant announced today that it has been awarded a $118.5M contract by the U.S. Air Force (USAF) to provide Simulator and Academic Instructor Pilots (SIM-IPs) to the Pacific Air Forces (PACAF), reaffirming Valiant’s commitment to enhancing USAF mission-readiness.
  • Under the contract, Valiant will deploy skilled Contract Instructor Pilots (CIPs) to develop mission-ready aircrews at six PACAF locations: Kadena Air Base, Okinawa, Japan; Misawa Air Base, Japan; Kunsan Air Base, South Korea; Osan Air Base, South Korea; Joint Base Elmendorf–Richardson, Alaska; and Joint Base Pearl Harbor-Hickam, Hawaii.
  • These CIPs will provide instruction on various aircraft platforms, including the F-15C, E-3 AWACS, F-16, A-10C, and F-22A.
  • "We are honored to have been selected by the USAF to advance mission readiness for the Pacific Air Forces,” said Dan Corbett, Chief Executive Officer at Valiant.

Style3D Research Shines the Show with additional Two Papers Accepted at SIGGRAPH ASIA 2023 on Cloth Simulation Innovations

Retrieved on: 
Wednesday, January 10, 2024

SYDNEY, Jan. 10, 2024 /PRNewswire/ -- The electrifying stage of SIGGRAPH Asia 2023 witnessed Style3D Research's triumphant unveiling of two groundbreaking research papers through captivating oral presentations.

Key Points: 
  • SYDNEY, Jan. 10, 2024 /PRNewswire/ -- The electrifying stage of SIGGRAPH Asia 2023 witnessed Style3D Research's triumphant unveiling of two groundbreaking research papers through captivating oral presentations.
  • Style3D Simulator: A hyper-realistic clothing simulation plugin for CG industry applications, enhancing clothing animation production efficiency for any UE project.
  • Style3D Research is a pioneering hub dedicated to pushing the boundaries of computer graphics and simulation technologies.
  • Committed to innovation, Style3D Research strives to revolutionize the digital fashion industry through cutting-edge research and development.

FICO Supercharges Business Outcomes with Innovations in Simulation Technology on FICO Platform

Retrieved on: 
Monday, January 8, 2024

FICO will be showcasing the innovations and use cases for FICO® Platform at FICO® World, FICO’s premiere client event, on April 15-18, 2024, in San Diego.

Key Points: 
  • FICO will be showcasing the innovations and use cases for FICO® Platform at FICO® World, FICO’s premiere client event, on April 15-18, 2024, in San Diego.
  • “With the new advances from FICO Platform, our customers are able to deliver compelling new consumer value and achieve their strategic business outcomes.”
    As a leader in analytics and applied intelligence platform technology, FICO helps clients deliver exceptional hyper-personalized customer experiences.
  • FICO® Platform powers enterprises to drive the most critical and strategic business outcomes across the customer lifecycle.
  • FICO® Platform emphasizes a level of collaboration and business composability that empowers the internal teams that are driving the digital innovation agenda of FICO Platform clients.

Turbine Announces Collaboration to Uncover Biological Mechanisms of Drug Resistance in Hematological Cancers

Retrieved on: 
Friday, January 5, 2024

Turbine, a leading biological simulation company building a platform for interpreting human biology in silico, today announced it has entered into a collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN), a global biopharmaceutical company.

Key Points: 
  • Turbine, a leading biological simulation company building a platform for interpreting human biology in silico, today announced it has entered into a collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN), a global biopharmaceutical company.
  • Turbine will use its proprietary Simulated Cell™ platform to identify and understand mechanisms of resistance to therapy in hematological cancers.
  • The collaboration will focus on understanding resistance mechanisms resulting from altered protein-protein interactions, which could enable more personalized treatment regimens based on each patient’s molecular profile.
  • Simulations were used to identify potential mechanisms underlying the synergy between combinations of cancer treatments, revealing biomarkers of response and resistance that could be translated into clinical practice.

Sift Unveils Workflow Simulation to Enhance Automated Fraud Defense

Retrieved on: 
Tuesday, December 12, 2023

While automation is crucial for scaling fraud prevention and improving customer experience, it can be complex and resource-intensive to optimize.

Key Points: 
  • While automation is crucial for scaling fraud prevention and improving customer experience, it can be complex and resource-intensive to optimize.
  • Sift’s platform provides tailored Workflows, a dynamic and Machine Learning (ML)-based advancement to traditional rules-based fraud detection, that empowers greater flexibility and simplicity.
  • Key features of Workflow Simulation include:
    Visual based reports showing the direct impacts of fraud criteria changes on key performance indicators (e.g.
  • Workflow Simulation empowers these teams to take decisive, informed action without the need for significant additional resources.